Deep vein thrombosis prophylaxis in patients who undergo knee arthroscopy: a systematic review

Authors: Udit Dave, Emma G. Lewis, Victoria K. Ierulli, Shreya M. Saraf, Mary K. Mulcahey

Source: Knee Surgery & Related Research, Vol 36, Iss 1, Pp 1-10 (2024)

Subject Terms: Deep vein thrombosis, Venous thromboembolism, DVT prophylaxis, Factor Xa inhibitor, Aspirin, Knee arthroscopy, Orthopedic surgery, RD701-811

File Description: electronic resource

Relation: https://doaj.org/toc/2234-2451

Access URL: https://doaj.org/article/54b7617f7cc04d97867a7e41fa556567

Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study

Authors: Kwon S, Lee SR, Choi EK, Lee KY, Choi J, Ahn HJ, Oh S, Lip GYH

Source: Vascular Health and Risk Management, Vol Volume 20, Pp 231-244 (2024)

Subject Terms: atrial fibrillation, direct factor xa inhibitor, bleeding, oral anticoagulant, perioperative care., Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.dovepress.com/perioperative-management-in-patients-with-atrial-fibrillation-treated--peer-reviewed-fulltext-article-VHRM; https://doaj.org/toc/1178-2048

Access URL: https://doaj.org/article/6525f9a53cc94f24a6190a0c97143fe7

Facial trauma with life-threatening bleeding treated by andexanet alfa administration: A case report

Authors: Yasunori Shirakawa, Naoto Jingami, Yoshitaka Ishiguro, Takuma Minami, Ken Shinozuka, Tomoyuki Yunoki, Shigeru Ohtsuru

Source: Heliyon, Vol 10, Iss 17, Pp e36922- (2024)

Subject Terms: Case report, Anticoagulant reversal, Facial fracture, Extravasation, Andexanet alfa, Factor Xa inhibitor, Science (General), Q1-390, Social sciences (General), H1-99

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844024129532; https://doaj.org/toc/2405-8440

Access URL: https://doaj.org/article/80c13a9bf30f4dd7a906934af0078673

Edoxaban eliminates hypercoagulability evoked by transient temperature changes in human whole blood

Authors: Anna Suzuki, Satomi Hamada, Ai Oono, Yuki Hasegawa, Yasuteru Yamauchi, Kaoru Okishige, Kenzo Hirao, Tetsuo Sasano

Source: Journal of Arrhythmia, Vol 39, Iss 6, Pp 901-908 (2023)

Subject Terms: atrial fibrillation, catheter ablation, coagulability, dielectric blood coagulometry, factor Xa inhibitor, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/1880-4276; https://doaj.org/toc/1883-2148

Access URL: https://doaj.org/article/41619e29e3da4de58b44c03528c3547c

Management of traumatic cervical epidural hematoma in patients on Xa-inhibitors: a case report and review of the literature

Authors: Robert Dang, Leo Issagholian, Tegan Schmidt, Pasha Raoufi, Cameron C. Neeki, Michael M. Neeki

Source: Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-6 (2023)

Subject Terms: Trauma, Epidural hematoma, Anticoagulation reversal, Thromboelastogram, Factor Xa inhibitor, Prothrombin concentrate, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1752-1947

Access URL: https://doaj.org/article/6b3c78d54fbb4305ae7db50d011c9530

Case report: Severe hepatopathy following rivaroxaban administration in a dog

Authors: Allison P. Mosichuk, Candace Wimbish, Kristen Poplawski, Adam Birkenheuer, Karyn Harrell, Kursten V. Pierce

Source: Frontiers in Veterinary Science, Vol 11 (2024)

Subject Terms: rivaroxaban, hepatopathy, canine, anticoagulant, factor Xa inhibitor, Veterinary medicine, SF600-1100

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fvets.2024.1364677/full; https://doaj.org/toc/2297-1769

Access URL: https://doaj.org/article/b6ff73d8be434896b55fafb9220d5327

Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet‐dependent thrombin generation in cats

Authors: Sara T. Lo, Ronald H. L. Li, Catherine J. Georges, Nghi Nguyen, Cheyenne K. Chen, Claire Stuhlmann, Maureen Sigmund Oldach, Victor Noel Rivas, Samantha Fousse, Samantha P. Harris, Joshua A. Stern

Source: Journal of Veterinary Internal Medicine, Vol 37, Iss 4, Pp 1390-1400 (2023)

Subject Terms: cardiology, cardiovascular, clopidogrel resistance, factor Xa inhibitor, hypertrophic cardiomyopathy, saddle thrombus, Veterinary medicine, SF600-1100

File Description: electronic resource

Relation: https://doaj.org/toc/0891-6640; https://doaj.org/toc/1939-1676

Access URL: https://doaj.org/article/37da3c77fb914dde8637aebb05fb0b69

Three cases of neutralization of factor Xa inhibitors with andexanet alfa under rotational thromboelastography monitoring

Authors: Takeshi Yagi, Reina Kawano, Takuto Tomokage, Ryo Ayata, Yasutaka Koga, Kotaro Kaneda, Motoki Fujita, Nanami Yamanaka, Naomasa Mori, Ryosuke Tsuruta

Source: Acute Medicine & Surgery, Vol 11, Iss 1, Pp n/a-n/a (2024)

Subject Terms: andexanet alfa, clotting time, DOAC, factor Xa inhibitor, ROTEM, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

File Description: electronic resource

Relation: https://doaj.org/toc/2052-8817

Access URL: https://doaj.org/article/16b5cf1b0a644c2faf66578c076cf71a

Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial

Authors: Gerald Chi, Fahad AlKhalfan, Jane J. Lee, Sahar Memar Montazerin, Clara Fitzgerald, Serge Korjian, Wally Omar, Elliot Barnathan, Alexei Plotnikov, C. Michael Gibson

Source: Frontiers in Cardiovascular Medicine, Vol 10 (2024)

Subject Terms: stent thrombosis (ST), acute coronary syndrome (ACS), percutaneous coronary intervention (PCI), myocardial infarction (MI), rivaroxaban, factor Xa inhibitor, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2023.1269011/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/6965df1a5df94275ab8e07cefc410308

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most

Authors: Mauricio Concha, Lizhen Xu, MacKenzie Horn, Tomoyuki Ohara, Juliet Nakamya, Jan Beyer‐Westendorf, Ashkan Shoamanesh, Alexander Cohen, Per Ladenvall, Stuart J. Connolly, Andrew M. Demchuk

Source: Stroke: Vascular and Interventional Neurology, Vol 4, Iss 1 (2024)

Subject Terms: andexanet alfa, anti‐factor Xa activity, direct factor Xa inhibitor reversal, hematoma expansion, intracranial hemorrhage, Neurology. Diseases of the nervous system, RC346-429, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://doaj.org/toc/2694-5746

Access URL: https://doaj.org/article/9afe5c2bf3dd4bf3923c253ead8387eb

Definition of factor Xa inhibitor–related, life‐threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel

Authors: Fermann, Gregory J. ¹, Cash, Brooks D. ^{2, *}, Coelho‐Prabhu, Nayantara ³, Maegele, Marc ⁴, Bingisser, Roland ⁵, Sehgal, Vinay ⁶, Cohen, Alexander T. ⁷, Golden, Anna Hundt ⁸, Russo, Jon ⁸, Price, Mark ⁸, Mangel, Allen ⁸, Koch, Bruce ⁹, Christoph, Mary J. ⁹, Milling, Truman J., Jr. ¹⁰

Source: In JACEP Open October 2023 4(5)

Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study

Authors: Thorsten R. Doeppner, Linus Olbricht, Toska Maxhuni, Omar Alhaj Omar, Ulrich J. Sachs, Martin B. Juenemann, Hagen B. Huttner, Stefan T. Gerner

Source: Frontiers in Neurology, Vol 14 (2023)

Subject Terms: point-of-care test, direct oral anticoagulant, factor-Xa-inhibitor, anticoagulation, ischemic stroke, Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fneur.2023.1330421/full; https://doaj.org/toc/1664-2295

Access URL: https://doaj.org/article/6ff62a8a7835481fb7704f6f7554c6e8

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Authors: Olivia S. Costa, Stuart J. Connolly, Mukul Sharma, Jan Beyer-Westendorf, Mary J. Christoph, Belinda Lovelace, Craig I. Coleman

Source: Critical Care, Vol 26, Iss 1, Pp 1-13 (2022)

Subject Terms: Andexanet alfa, Four-factor prothrombin complex concentrate, Direct factor Xa inhibitor reversal, Intracranial hemorrhage, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

File Description: electronic resource

Relation: https://doaj.org/toc/1364-8535

Access URL: https://doaj.org/article/5a95a8a8d12246ddbc13b48e098b4962

Effects of rivaroxaban and apixaban on intimal hyperplasia in rabbits

Authors: Mustafa Baris Kemahli, Tugra Gencpinar, Huseyin Dursun, Cagatay Bilen, Pinar Akokay, Serdar Bayrak, Abidin Cenk Erdal

Source: Turkish Journal of Vascular Surgery, Vol 31, Iss 3, Pp 148-56 (2022)

Subject Terms: rivaroxaban, apixaban, intimal hyperplasia, thromboprophylaxis, factor xa inhibitor, Surgery, RD1-811, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://turkishjournalofvascularsurgery.org//?mno=112373; https://doaj.org/toc/2667-5080

Access URL: https://doaj.org/article/58d01566d84943a1805e807c9300ea9e

Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism

Authors: Yamaura, Genpei ^a, Ito, Takeshi ^b, Miyaji, Yosuke ^c, Ueda, Naohisa ^d, Nakae, Yoshiharu ^e, Momoo, Takayuki ^f, Nakano, Tatsu ^g, Johmura, Yuji ^h, Higashiyama, Yuichi ^c, Joki, Hideto ^c, Doi, Hiroshi ^c, Takeuchi, Hideyuki ^c, Takahashi, Tatsuya ⁱ, Koyano, Shigeru ^h, Yamaguchi, Shigeki ^b, Yokoyama, Mutsumi ^a, Tanaka, Fumiaki ^{c, ⁎}

Source: In Thrombosis Research October 2021 206:99-103

Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre

Authors: Anadil Faqah, Hassan Sheikh, Muhammad Abu Bakar, Fatima Tayyaab, Sahrish Khawaja

Source: Thrombosis Journal, Vol 18, Iss 1, Pp 1-6 (2020)

Subject Terms: Anticoagulants, Rivaroxaban, Factor Xa inhibitor, Thrombosis, Low-molecular-weight-heparin, Cancer-associated-thrombosis, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12959-020-00221-2; https://doaj.org/toc/1477-9560

Access URL: https://doaj.org/article/64ddbf76998d4bac82e487ae581c61ad

Calibration and validation of the rabbit model of electrolytic‐mediated arterial thrombosis against the standard‐of‐care anticoagulant apixaban

Authors: Pancras C. Wong, Earl Crain

Source: Pharmacology Research & Perspectives, Vol 10, Iss 3, Pp n/a-n/a (2022)

Subject Terms: anticoagulant, blood coagulation, factor Xa inhibitor, thrombosis, translation, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2052-1707

Access URL: https://doaj.org/article/4919001a5b4445e2b09afc2f75d7f64c

Direct oral anticoagulants‐Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors

Authors: Danielle White, Gary W. Moore, Martin Besser, Stephen MacDonald, Will Thomas

Source: Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)

Subject Terms: antiphospholipid syndrome, charcoal adsorption, DOAC Remove™, factor Xa inhibitor, lupus anticoagulant, Taipan snake venom time, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2475-0379

Access URL: https://doaj.org/article/d684b1de20ca4a7b915898cb4bb4ca1b

Factor Xa inhibitor for venous thromboembolism management in patient with cancer: a systematic review and meta-analysis [version 1; peer review: 2 approved]

Authors: Ardyan Wardhana, Johanes Nugroho Eko Putranto, Pirhot Lambok Marnala Yosua Siahaan, Yoga Alfian Noor, Makhyan Jibril Al Farabi

Source: F1000Research, Vol 10 (2021)

Subject Terms: bleeding, cancer, factor Xa inhibitor, oral anticoagulant, venous thromboembolism., eng, Medicine, Science

File Description: electronic resource

Relation: https://f1000research.com/articles/10-1257/v1; https://doaj.org/toc/2046-1402

Access URL: https://doaj.org/article/e212ff452b3948958a4045d7ad26e298

Management of patients taking antithrombotic drugs before dental surgery

Authors: Ju-Hsuan Yang, Hsin-Ming Chen, Ying-Shiung Kuo, Chun-Pin Chiang

Source: Journal of Dental Sciences, Vol 15, Iss 2, Pp 222-224 (2020)

Subject Terms: Antiplatelet agent, Anticoagulant, Vitamin K antagonist, Factor Xa inhibitor, Thrombin inhibitor, Dentistry, RK1-715

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1991790220300623; https://doaj.org/toc/1991-7902

Access URL: https://doaj.org/article/00934f24d23d4edfa3565d2f44b9c061